abrdn Healthcare Investors vs. NVIDIA Corporation
abrdn Healthcare Investors (HQH) comes out ahead, leading on 2 of 3 compared factors.
Size & Scale
| HQH | NVDA | |
|---|---|---|
| Market Cap | $1.23 billion | $5.37 trillion |
| Revenue (TTM) | — | $302.97 billion |
| Net Income (TTM) | — | $192.88 billion |
NVDA leads on 1 of 1 size & scale factors.
Valuation
| HQH | NVDA | |
|---|---|---|
| P/E Ratio | — | 28.10 |
| Price / Book | — | 23.44 |
| Price / Sales | — | 17.72 |
HQH and NVDA split the valuation factors evenly.
Profitability
| HQH | NVDA | |
|---|---|---|
| Net Margin | — | 63.66% |
| Return on Equity | — | 84.23% |
HQH and NVDA split the profitability factors evenly.
Dividend
| HQH | NVDA | |
|---|---|---|
| Dividend Yield | 12.31% | 0.45% |
| Payout Ratio | — | 12.64 |
HQH leads on 1 of 1 dividend factors.
Risk & Sentiment
| HQH | NVDA | |
|---|---|---|
| Short Interest | 0.01% | 0.07% |
HQH leads on 1 of 1 risk & sentiment factors.
Dig deeper: HQH overview, HQH financials, NVDA overview, NVDA financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.